Emcure Pharma Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.934166625
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

In 2 Starfolio Baskets

about

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

1881.00 11.50 (0.62%)

Near 52W High of ₹1944.00

62,196

NSE+BSE Volume

NSE 24 Jul, 2026 3:31 PM (IST)

Board Meeting

The next board meeting for Emcure Pharma is on 06 Aug 2026 for the purpose of Quarterly Results See details

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

68.9 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1,963

1Yr Price target upside is 4%

7 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharma Live Share Price Today, Share Analysis and Chart

Emcure Pharmaceuticals Ltd. is a vertically integrated pharmaceutical company based in India with a significant global presence, particularly in the domestic, European, and Canadian markets. The company specializes in developing, manufacturing, and m...

Near 52W High of ₹1944.00

SWOT Analysis

Emcure Pharma Live Price Chart

Emcure Pharma Live Price Chart